Terms: = Brain cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Treatment
144 results:
1. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
2. Aberrant atm signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization.
Chen J; Laverty DJ; Talele S; Bale A; Carlson BL; Porath KA; Bakken KK; Burgenske DM; Decker PA; Vaubel RA; Eckel-Passow JE; Bhargava R; Lou Z; Hamerlik P; Harley B; Elmquist WF; Nagel ZD; Gupta SK; Sarkaria JN
Sci Transl Med; 2024 Feb; 16(734):eadj5962. PubMed ID: 38354228
[TBL] [Abstract] [Full Text] [Related]
3. Reasoning and causal inference regarding surgical options for patients with low-grade gliomas using machine learning: A SEER-based study.
Zhu E; Shi W; Chen Z; Wang J; Ai P; Wang X; Zhu M; Xu Z; Xu L; Sun X; Liu J; Xu X; Shan D
Cancer Med; 2023 Nov; 12(22):20878-20891. PubMed ID: 37929878
[TBL] [Abstract] [Full Text] [Related]
4. Management and risk of postoperative bleeding in patients with low-dose antiplatelet aspirin medication during endoscopic endonasal surgery for pituitary adenomas.
Enciu A; Loeschner D; Alhallak M; Kellner G; Meyer A; Lauten A; Steinbrecher A; Gerlach R
Acta Neurochir (Wien); 2023 Oct; 165(10):2995-3001. PubMed ID: 37668789
[TBL] [Abstract] [Full Text] [Related]
5. atm-Inhibitor AZD1390 Is a Radiosensitizer for Breast cancer CNS Metastasis.
Tew BY; Kalfa AJ; Yang Z; Hurth KM; Simon T; Abnoosian E; Durant ST; Hamerlik P; Salhia B
Clin Cancer Res; 2023 Nov; 29(21):4492-4503. PubMed ID: 37585496
[TBL] [Abstract] [Full Text] [Related]
6. Veratramine Inhibits the Cell Cycle Progression, Migration, and Invasion via atm/ATR Pathway in Androgen-Independent Prostate cancer.
Kim HY; Lee SW; Choi SK; Ashim J; Kim W; Beak SM; Park JK; Han JE; Cho GJ; Ryoo ZY; Jeong J; Lee YH; Jeong H; Yu W; Park S
Am J Chin Med; 2023; 51(5):1309-1333. PubMed ID: 37385965
[TBL] [Abstract] [Full Text] [Related]
7. Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer.
Lee K; Lee J; Choi J; Sim SH; Kim JE; Kim MH; Park YH; Kim JH; Koh SJ; Park KH; Kang MJ; Ahn MS; Lee KE; Kim HJ; Ahn HK; Kim HJ; Park KU; Park IH
Sci Rep; 2023 Jun; 13(1):9928. PubMed ID: 37336919
[TBL] [Abstract] [Full Text] [Related]
8. Reduced YAP1 and FOLR1 in gliomas predict better response to chemotherapeutics.
Patrick S; Lathoria K; Suri V; Sen E
Cell Signal; 2023 Sep; 109():110738. PubMed ID: 37269960
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer.
Wolff L; Steindl A; Popov P; Dieckmann K; Gatterbauer B; Widhalm G; Berghoff AS; Preusser M; Raderer M; Kiesewetter B
Clin Exp Metastasis; 2023 Jun; 40(3):217-226. PubMed ID: 37219741
[TBL] [Abstract] [Full Text] [Related]
10. Identification of FKBP10 prognostic value in lung adenocarcinoma patients with surgical resection of brain metastases: A retrospective single-institution cohort study.
Liu ZD; Wang SQ; Li S; He J; Wang SH; Cai HQ; Wan JH
Clinics (Sao Paulo); 2023; 78():100212. PubMed ID: 37201304
[TBL] [Abstract] [Full Text] [Related]
11. Bleeding risk and mortality according to antithrombotic agents' exposure in cancer-related stroke patients: nationwide population-based cohort study in South Korea.
Choi BK; Lee JS; Kim HR; Kim HS; Jung YH; Park YR
BMC Neurol; 2023 May; 23(1):187. PubMed ID: 37161360
[TBL] [Abstract] [Full Text] [Related]
12. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs.
Pirlog BO; Ilut S; Pirlog R; Chiroi P; Nutu A; Radutiu DI; Cuc GD; Berindan-Neagoe I; Nabavi SF; Filosa R; Nabavi SM
Expert Rev Mol Med; 2023 May; 25():e18. PubMed ID: 37154101
[TBL] [Abstract] [Full Text] [Related]
13. Lenvatinib Administration for Anaplastic Thyroid Carcinoma with brain Metastasis.
Obayashi A; Aoki K; Wada T; Furuie H; Kuraoka K; Hamamoto T; Tatsukawa T
Acta Med Okayama; 2023 Apr; 77(2):227-232. PubMed ID: 37094963
[TBL] [Abstract] [Full Text] [Related]
14. atm inhibition enhances the efficacy of radiation across distinct molecular subgroups of pediatric high-grade glioma.
Xie J; Kuriakose T; Bianski B; Twarog N; Savage E; Xu K; Zhu X; He C; Hansen B; Wang H; High A; Li Y; Rehg JE; Tillman HS; Freeman BB; Rankovic Z; Onar-Thomas A; Fan Y; Wu G; Peng J; Miller S; Baker SJ; Shelat AA; Tinkle CL
Neuro Oncol; 2023 Oct; 25(10):1828-1841. PubMed ID: 36971093
[TBL] [Abstract] [Full Text] [Related]
15. Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance.
Carney SV; Banerjee K; Mujeeb A; Zhu B; Haase S; Varela ML; Kadiyala P; Tronrud CE; Zhu Z; Mukherji D; Gorla P; Sun Y; Tagett R; Núñez FJ; Luo M; Luo W; Ljungman M; Liu Y; Xia Z; Schwendeman A; Qin T; Sartor MA; Costello JF; Cahill DP; Lowenstein PR; Castro MG
Clin Cancer Res; 2023 May; 29(9):1763-1782. PubMed ID: 36692427
[TBL] [Abstract] [Full Text] [Related]
16. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease.
Portman MA; Jacobs JP; Newburger JW; Berger F; Grosso MA; Duggal A; Tao B; Goldenberg NA;
J Am Coll Cardiol; 2022 Dec; 80(24):2301-2310. PubMed ID: 36328157
[TBL] [Abstract] [Full Text] [Related]
17. Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study.
Serra-Bellver P; Versluis JM; Oberoi HK; Zhou C; Slattery TD; Khan Y; Patrinely JR; Pires da Silva I; Martínez-Vila C; Cook N; Graham DM; Carlino MS; Menzies AM; Arance AM; Johnson DB; Long GV; Pickering L; Larkin JMG; Blank CU; Lorigan P
Eur J Cancer; 2022 Nov; 176():121-132. PubMed ID: 36215945
[TBL] [Abstract] [Full Text] [Related]
18. ZSTK474 Sensitizes Glioblastoma to Temozolomide by Blocking Homologous Recombination Repair.
Jiao W; Zhu S; Shao J; Zhang X; Xu Y; Zhang Y; Wang R; Zhong Y; Kong D
Biomed Res Int; 2022; 2022():8568528. PubMed ID: 35872860
[TBL] [Abstract] [Full Text] [Related]
19. Chronically Radiation-Exposed Survivor Glioblastoma Cells Display Poor Response to Chk1 Inhibition under Hypoxia.
Pinarbasi-Degirmenci N; Sur-Erdem I; Akcay V; Bolukbasi Y; Selek U; Solaroglu I; Bagci-Onder T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806055
[TBL] [Abstract] [Full Text] [Related]
20. cancer Risk C (CR-C), a functional genomics test is a sensitive and rapid test for germline mismatch repair deficiency.
Alim I; Loke J; Yam S; Templeton AS; Newcomb P; Lindor NM; Pai RK; Jenkins MA; Buchanan DD; Gallinger S; Klugman S; Ostrer H
Genet Med; 2022 Sep; 24(9):1821-1830. PubMed ID: 35616648
[TBL] [Abstract] [Full Text] [Related]
[Next]
